| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 320.095.902 $ | +21.624.507 $ | +97,4 % | 298.471.395 $ | +83.878.399 $ | +35,5 % | 214.592.996 $ | +44.948.667 $ | +1.449,1 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 171.647.683 $ | +18.482.699 $ | +12,1 % | 153.164.984 $ | +46.485.818 $ | +43,6 % | 106.679.166 $ | +5.670.412 $ | +5,6 % |
| ARGENX SE | ARGX | 119.414.900 $ | +8.780.900 $ | +7,9 % | 110.634.000 $ | +27.963.678 $ | +33,8 % | 82.670.322 $ | +14.605.847 $ | +21,5 % |
| CORCEPT THERAPEUTICS INC | CORT | 18.433.386 $ | -14.173.243 $ | -43,5 % | 32.606.629 $ | +7.363.121 $ | +29,2 % | 25.243.508 $ | +24.672.408 $ | +4.320,2 % |
| CYTOKINETICS INC | CYTK | 10.599.933 $ | +8.534.151 $ | +413,1 % | 2.065.782 $ | +2.065.782 $ | ||||
| 320.095.902 $ | +21.624.507 $ | +97,4 % | 298.471.395 $ | +83.878.399 $ | +35,5 % | 214.592.996 $ | +44.948.667 $ | +1.449,1 % | ||